FLOVENT DISKUS
ICS DPI
Fluticasone propionate · GlaxoSmithKline
Discontinued by manufacturer
GSK discontinued branded Flovent in the US effective January 1, 2024. An identical authorized generic (fluticasone propionate inhalation powder, distributed by Prasco) remains available.
GSK position on FloventActive Medication & Mechanism
- Fluticasone propionate ICS50 mcg, 100 mcg, or 250 mcg per blister
Synthetic corticosteroid with potent anti-inflammatory activity. Inhibits multiple cell types (mast cells, eosinophils, macrophages) and mediators involved in airway inflammation.
FDA-Approved Dosing — Strength × Indication
Strength Regimen Asthma
100 mcg
1 inhalation twice daily → 200 mcg
FDA Approved
For patients previously on ICS or bronchodilators alone who require a moderate step-up.
250 mcg
1 inhalation twice daily → 500 mcg
FDA Approved
For patients previously on other ICS or oral corticosteroids. Maximum dose is 500 mcg twice daily (1000 mcg/day).
All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling
100 mcg 1 inhalation twice daily → 200 mcg
Asthma FDA Approved
For patients previously on ICS or bronchodilators alone who require a moderate step-up.
250 mcg 1 inhalation twice daily → 500 mcg
Asthma FDA Approved
For patients previously on other ICS or oral corticosteroids. Maximum dose is 500 mcg twice daily (1000 mcg/day).
All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling
Not a rescue inhaler. Not for acute use. Use a SABA.
Related Inhalers
Same active ingredients (Fluticasone)